FDA Biologics (BLA & Biosimilars)Original article
FDA Scientific Public Workshop: Next-Generation Sequencing for Adventitious Agent Detection in Biologics – September 23, 2026 - 09/23/2026
ConferenceNeutral
AI Analysis
Summary
The FDA will host a scientific workshop on September 23, 2026 to discuss next-generation sequencing technologies for adventitious agent detection in biological products, bringing together subject matter experts and stakeholders to address readiness, challenges, and solutions for adoption.
Importance:3/10
Sentiment:
0.00
FDA WorkshopNext-Generation SequencingNGSAdventitious Agent DetectionBiologicsRegulatory
Related Companies
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 22, 2026 7:59 PM